SML0848

LM22A-4

≥98% (HPLC), Potent TrkB agonist, powder

• Synonim(y): N1,N3,N5-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
• Wzór empiryczny (zapis Hilla): C₁₅H₂₁N₃O₆
• Numer CAS: 37988-18-4
• Masa cząsteczkowa: 339.34
• UNSPSC Code: 51111800
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Nazwa produktu: LM22A-4, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: H₂O: 2 mg/mL, clear (warmed)
• storage temp.: 2-8°C
• SMILES string: N(CCO)C(=O)c1cc(cc(c1)C(=O)NCCO)C(=O)NCCO
• InChI: 1S/C15H21N3O6/c19-4-1-16-13(22)10-7-11(14(23)17-2-5-20)9-12(8-10)15(24)18-3-6-21/h7-9,19-21H,1-6H2,(H,16,22)(H,17,23)(H,18,24)
• InChI key: RGWJKANXFYJKHN-UHFFFAOYSA-N

Opis

Application

LM22A-4 has been used as a component of dissociation medium for mouse embryonic stem cells (mESC) and human embryonic stem (hESC) aggregates.

Biochem/physiol Actions

LM22A-4 is a partial agonist of TrkB, a brain-derived neurotrophic factor (BDNF) receptor. In binding assays, LM22A-4 displaces BDNF with an IC₅₀ of 47 nM. The compound restores TrkB phosphorylation and respiratory function in a mouse model of Rett syndrome.

LM22A-4 is a partial agonist of TrkB.

LM22A-4 is a non-peptide and shares similarity with brain-derived neurotrophic factor (BDNF), especially in the loop2 region. It improves oligodendroglia density and favors myelin repair. LM22A-4 elevates the expression of protein kinase B (PKB or Akt) and extracellular signal-regulated kinases (ERKs). LM22A-4 elicits neuroprotection in spinal cord injury (SCI) by deregulating the cleaved-caspase-3 and favoring B-cell lymphoma 2(Bcl-2) expression.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable